To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 1994

Primary Completion Date

May 31, 1994

Study Completion Date

May 31, 1994

Conditions

Inflammation

Interventions

DRUG

Diclofenac Sodium 75 mg Tablets Under Fasting Conditions (Geneva Pharmaceutical)

DRUG

Diclofenac Sodium 75 mg Tablets Under Fed Conditions (Geneva Pharmaceutical)

DRUG

Voltaren 75 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)